C. Praml et al., CLONING OF THE HUMAN AFLATOXIN B-1-ALDEHYDE REDUCTASE GENE AT 1P35-1P36.1 IN A REGION FREQUENTLY ALTERED IN HUMAN TUMOR-CELLS, Cancer research, 58(22), 1998, pp. 5014-5018
Alterations of the distal portion of the short arm of chromosome 1 (1p
) are among the earliest abnormalities of human colorectal tumors. Los
s of heterozygosity analysis has previously revealed a smallest region
of overlapping deletion (SRO) B, at 1p35-36.1, deleted in 48% of spor
adic tumors. From this region we have now cloned a gene encoding a pro
tein of 330 amino acids that is 78% identical with the Rattus norvegic
us aflatoxin B-1 aldehyde reductase (Afar) and, therefore, likely repr
esents its human homologue. In rat liver, Afar is strongly inducible b
y the antioxidants ethoxyquin and butylated hydroxyanisole, which prot
ect the rat against aflatoxin B-1-induced liver tumorigenesis by detox
ifying its genotoxic and cytotoxic dialdehyde. Human AFAR is expressed
in a broad range of tissues and, therefore, is likely involved in end
ogenous detoxication pathways. Impaired detoxication of genotoxic alde
hydes and ketones, which are involved in tumorigenesis of the colon an
d breast, may he a crucial factor both for tumor initiation and progre
ssion. We here provide a detailed contig of 1.5-2 Mbp/2.7 cM encompass
ing part of SRO B, including known genes and previously unmapped expre
ssed sequence tags. PLA2G2A (secretory type II phospholipase A(2)), de
scribed previously as a candidate, is localized outside SRO B.